Open access · CC-BY
via OpenAlex
Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
Lan Ye, Anne L. Widlund, Carrie A. Sims, Dudley W. Lamming, Yuxia Guan, James G. Davis, David M. Sabatini, David E. Harrison, Ole Vang, Joseph A. Baur
Aging · 2013 · ▲ 56 citations
Abstract
mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) extends lifespan in mice, but can have a number of undesirable effects that may ultimately limit its utility in humans. The canonical target of rapamycin, and the one thought to account for its effects on lifespan, is the mammalian/mechanistic target of rapamycin, complex 1 (mTORC1). We have previously shown that at least some of the detrimental side effects of rapamycin are due to "off target" disruption of mTORC2, suggesting they could be avoided by more specific targeting of mTORC1. However, mTORC1 inhibitionper se can reduce the mRNA expression of mitochondrial genes and compromise the function of mitochondria in cultured muscle cells, implying that defects in bioenergetics might be an unavoidable consequence of targeting mTORC1 in vivo. Therefore, we tested whether rapamycin, at the same doses used to extend lifespan, affects mitochondrial function in skeletal muscle. While mitochondrial transcripts were decreased, particularly in the highly oxidative soleus muscle, we found no consistent change in mitochondrial DNA or protein levels. In agreement with the lack of change in mitochondrial components, rapamycin-treated mice had endurance equivalent to that of untreated controls, and isolated, permeabilized muscle fibers displayed similar rates of oxygen consumption. We conclude that the doses of rapamycin required to extend life do not cause overt mitochondrial dysfunction(definition) in skeletal muscle.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.100576
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Ye, L., Widlund, A.L., Sims, C.A., Lamming, D.W., Guan, Y., Davis, J.G., Sabatini, D.M., Harrison, D.E., Vang, O., & Baur, J.A. (2013). Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance. <em>Aging</em>. https://doi.org/10.18632/aging.100576
Vancouver
Ye L, Widlund AL, Sims CA, Lamming DW, Guan Y, Davis JG, et al. Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance. Aging. 2013. doi:10.18632/aging.100576.
BibTeX
@article{lan2013Rapamy,
title = {Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance},
author = {Lan Ye and Anne L. Widlund and Carrie A. Sims and Dudley W. Lamming and Yuxia Guan and James G. Davis and David M. Sabatini and David E. Harrison and Ole Vang and Joseph A. Baur},
journal = {Aging},
year = {2013},
doi = {10.18632/aging.100576},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuroscience 2012
Preprint · OA
Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice
Mechanisms of Ageing and Development 2010
Citation only
Mitochondrial electron transport chain dysfunction during development does not extend lifespan in Drosophila melanogaster
PLoS ONE 2013
Open access · CC-BY
Mitochondrial Aminopeptidase Deletion Increases Chronological Lifespan and Oxidative Stress Resistance while Decreasing Respiratory Metabolism in S. cerevisiae
PubMed Central 2026
Preprint · CC-BY
Caenorhabditis Intervention Testing Program: the putative mTOR inhibitors Cinnarizine and Meclizine do not extend lifespan in C. elegans
American Journal Of Pathology 2010
Open access · OA
Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
PLoS ONE 2011
Open access · CC-BY